| Miss Karen Lynn Burnett, MD | |
|
6600 Fish Pond Rd, Suite 101, Waco, TX 76710-2581 | |
| (254) 776-3188 | |
| (254) 776-3671 |
| Full Name | Miss Karen Lynn Burnett |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 19 Years |
| Location | 6600 Fish Pond Rd, Waco, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144424060 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | N7402 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health Alliance | 6305731068 | 129 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology Meeting on Sunday, June 2.
COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade.
Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries.
Over the past few years, scientists have discovered that a new class of genetic regulators called "microRNAs" influences normal human growth and development. Now, researchers have found that microRNAs also play an important role in human cancer. The findings are published in today's issue of the journal Nature (June 9).
› Verified 7 days ago
| Entity Name | Providence Health Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932210838 PECOS PAC ID: 6305731068 Enrollment ID: O20040220000307 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology Meeting on Sunday, June 2.
COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade.
Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries.
Over the past few years, scientists have discovered that a new class of genetic regulators called "microRNAs" influences normal human growth and development. Now, researchers have found that microRNAs also play an important role in human cancer. The findings are published in today's issue of the journal Nature (June 9).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Karen Lynn Burnett, MD 6600 Fish Pond Rd, Suite 101, Waco, TX 76710-2581 Ph: (254) 776-3188 | Miss Karen Lynn Burnett, MD 6600 Fish Pond Rd, Suite 101, Waco, TX 76710-2581 Ph: (254) 776-3188 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology Meeting on Sunday, June 2.
COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade.
Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries.
Over the past few years, scientists have discovered that a new class of genetic regulators called "microRNAs" influences normal human growth and development. Now, researchers have found that microRNAs also play an important role in human cancer. The findings are published in today's issue of the journal Nature (June 9).
› Verified 7 days ago
Hope Shin, MD Surgery Medicare: Medicare Enrolled Practice Location: 150 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-4000 Fax: 254-202-4019 | |
Thomas Andrew Damato, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Dr. William H Turney, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6600 Fish Pond Rd, Suite 101, Waco, TX 76710 Phone: 254-776-3188 Fax: 254-776-3607 | |
Josh Harris Goldstrich, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6600 Fish Pond Rd Ste 101, Waco, TX 76710 Phone: 254-776-3188 Fax: 254-776-3607 | |
Dr. Ted R. Smith, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 50 Hillcrest Medical Blvd Ste 105, Waco, TX 76712 Phone: 254-202-7300 Fax: 254-202-7350 | |
Dr. Thomas John Goaley Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Trauma Services, Hillcrest Baptist Medical Center, Waco, TX 76712 Phone: 254-202-5300 Fax: 254-202-5349 |